Frederick, MD, United States of America

David Turner

This inventor holds 4 USPTO granted patents and 6 published patent applications. Top assignees: Leidos Biomedical Research, Inc., University of California, Lawrence Livermore National Security, LLC. Active years: 2020-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Turner. Retrieved from https://idiyas.com/inventor/david-turner-tvtf842p

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 75.0

Average Co-Inventor Count = 7.5

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2020-2026

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of David Turner

Introduction

David Turner is a notable inventor based in Frederick, MD (US). He has made significant contributions to the field of cancer research through his innovative work on K-Ras modulators. With a total of 4 patents to his name, Turner has established himself as a key figure in the development of therapeutic methods for cancer treatment.

Latest Patents

Turner's latest patents focus on K-Ras modulators, which are crucial in the fight against cancer. One of his patents provides methods and compounds for inhibiting K-Ras, offering new avenues for cancer treatment. Another patent details K-Ras inhibitors of specific formulae, along with compositions that can be used for treating cancer. These innovations highlight his commitment to advancing medical science and improving patient outcomes.

Career Highlights

Throughout his career, David Turner has worked with prestigious institutions, including the University of California and Leidos Biomedical Research, Inc. His experience in these organizations has allowed him to collaborate with leading experts in the field, further enhancing his research capabilities.

Collaborations

Turner has collaborated with notable colleagues such as Frank McCormick and Adam Renslo. These partnerships have contributed to the depth and impact of his research, fostering an environment of innovation and discovery.

Conclusion

David Turner's work in developing K-Ras modulators represents a significant advancement in cancer treatment. His patents and collaborations reflect his dedication to improving healthcare through innovative solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…